Begoña Quintana-Villamandos Selected Research

esmolol (Brevibloc)

12/2019	Early reversal cardiac with esmolol in hypertensive rats: The role of subcellular organelle phenotype.
1/2018	Short-Term Treatment with Esmolol Reverses Left Ventricular Hypertrophy in Adult Spontaneously Hypertensive Rats via Inhibition of Akt/NF-κB and NFATc4.
11/2016	Short-term esmolol attenuates remodeling of the thoracic aorta in hypertensive rats by decreasing concentrations of ADMA down-regulated by oxidative stress.
10/2016	Early regression of coronary artery remodeling with esmolol and DDAH/ADMA pathway in hypertensive rats.
2/2016	Does the ADMA/DDAH/NO pathway modulate early regression of left ventricular hypertrophy with esmolol?
5/2013	Early regression of left ventricular hypertrophy after treatment with esmolol in an experimental rat model of primary hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Begoña Quintana-Villamandos Research Topics

Disease

11	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2020 - 09/2011
5	Hypertension (High Blood Pressure) 01/2019 - 02/2016
4	Atrial Fibrillation 01/2020 - 01/2017
3	Hypertrophy 01/2020 - 05/2013
2	Fibrosis (Cirrhosis) 06/2021 - 05/2013
2	Coronary Disease (Coronary Heart Disease) 01/2020 - 01/2019
2	Dyslipidemias (Dyslipidemia) 01/2020 - 01/2019
1	Vascular Remodeling 01/2017
1	Body Weight (Weight, Body) 01/2017
1	Heart Diseases (Heart Disease) 01/2017
1	Cardiomyopathies (Cardiomyopathy) 01/2017
1	Ventricular Remodeling 05/2013
1	Essential Hypertension 05/2013

Drug/Important Bio-Agent (IBA)

6	esmolol (Brevibloc)FDA LinkGeneric 12/2019 - 05/2013
5	Dronedarone FDA Link 01/2020 - 01/2017
3	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2019
2	CollagenIBA 01/2017 - 05/2013
1	Angiotensin IIIBA 06/2021
1	AntioxidantsIBA 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	Sulfhydryl Compounds (Thiols)IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019
1	Blood Proteins (Serum Proteins)IBA 01/2019
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2017
1	Antihypertensive Agents (Antihypertensives)IBA 11/2016
1	dimethylarginineIBA 02/2016
1	Nitric Oxide Synthase (NO Synthase)IBA 02/2016
1	dimethylargininaseIBA 02/2016
1	Adrenergic Antagonists (Antiadrenergic Agents)IBA 05/2013
1	albumin-bilirubin complexIBA 09/2011

Therapy/Procedure

2	Therapeutics 01/2017 - 11/2016
1	Aftercare (After-Treatment) 05/2013